(Q77779239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

T Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Song

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Z Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Lui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R S Jope

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

42-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/4723

8 December 2019

exact match

0 references

cites work

Programmed cell death in animal development

1 reference

7 January 2021

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

7 January 2021

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

1 reference

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

7 January 2021

Apoptosis by death factor

1 reference

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

7 January 2021

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

7 January 2021

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

7 January 2021

Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis

1 reference

7 January 2021

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction

1 reference

7 January 2021

A critical role for lymphotoxin in experimental allergic encephalomyelitis

1 reference

7 January 2021

The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase

1 reference

7 January 2021

The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase.

1 reference

7 January 2021

Dissociation of tyrosine phosphorylation and activation of phosphoinositide phospholipase C induced by the protein kinase C inhibitor Ro-31-8220 in Swiss 3T3 cells treated with platelet-derived growth factor

1 reference

7 January 2021

Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells

1 reference

7 January 2021

Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system

1 reference

7 January 2021

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

1 reference

7 January 2021

Identifiers

DOI

10.1038/4723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9883838%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference